Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1659617 · MBRX

Moleculin Biotech, Inc.

Filing with the SEC SEC-reporting company Houston, TX Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Sep 18, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$0$0
Net income (loss)$33.6M$26M
Total assets$22.1M$16.9M
Total liabilities$7.1M$5.7M
Stockholders’ equity$15M$11.2M
Cash and equivalents$8.9M$4.3M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Moleculin Biotech, Inc.
CIK
0001659617
Tickers
MBRX
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Houston, Texas
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 13, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Director or officer change: Director or officer change
    Form 8-K · items 5.02, 5.07, 9.01 · filed Oct 9, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 18, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Aug 25, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Aug 25, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jul 29, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 15, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 19, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 18, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Nov 21, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 13, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 12, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jun 27, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Jun 23, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jun 2, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed May 23, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 14, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 13, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Mar 31, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 24, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 21, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Dec 13, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 8, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Oct 25, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Aug 16, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 14, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 13, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jul 22, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 13, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 10, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 22, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 22, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Feb 2, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jan 5, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 13, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Nov 3, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 11, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 10, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 11, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 10, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed May 5, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 23, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 22, 2023 · filing